Supplementary
The predictive model building process was evaluated by leave-one-out cross-validation and permutation testing [21] . The performance of all model results based on permuted data indicated that the results reported in this table were not different from those expected by chance. Mutation data for 64 key cancer genes in 51 of the 58 p53 WT cell lines in our panel were collected from the Sanger COSMIC Cell Line Project (v61 release; cancer.sanger.ac.uk/cancergenome/projects/cell_lines/) [11] . Associations were evaluated between response to MDM2 inhibition and mutation status. 

